Related Experiment Video
Updated: Jun 14, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNAs and their target gene networks in breast cancer
1Immune Disease Institute, Program in Cellular and Molecular Medicine, Children's Hospital Boston and Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. odayel@gmail.com
Abstract:
MicroRNAs (miRNAs) are a major class of small endogenous RNA molecules that post-transcriptionally inhibit gene expression. Many miRNAs have been implicated in several human cancers, including breast cancer. Here we describe the association between altered miRNA signatures and breast cancer tumorigenesis and metastasis. The loss of several tumor suppressor miRNAs (miR-206, miR-17-5p, miR-125a, miR-125b, miR-200, let-7, miR-34 and miR-31) and the overexpression of certain oncogenic miRNAs (miR-21, miR-155, miR-10b, miR-373 and miR-520c) have been observed in many breast cancers. The gene networks orchestrated by these miRNAs are still largely unknown, although key targets have been identified that may contribute to the disease phenotype. Here we report how the observed perturbations in miRNA expression profiles may lead to disruption of key pathways involved in breast cancer.
Insights
Altered microRNA (miRNA) expression is linked to breast cancer development and spread. Changes in tumor suppressor and oncogenic miRNAs disrupt key cellular pathways, contributing to this complex disease.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small RNA molecules regulating gene expression post-transcriptionally.
- Aberrant miRNA expression is increasingly recognized in human cancers, particularly breast cancer.
- Specific miRNA signatures are associated with tumorigenesis and metastasis in breast cancer.
Purpose of the Study:
- To investigate the association between altered miRNA expression profiles and breast cancer.
- To identify specific tumor suppressor and oncogenic miRNAs involved in breast cancer.
- To understand how miRNA perturbations disrupt key pathways in breast cancer.
Main Methods:
- Analysis of miRNA expression profiles in breast cancer samples.
- Identification of differentially expressed tumor suppressor and oncogenic miRNAs.
- Investigation of miRNA targets and their role in disease pathways.
Main Results:
- Loss of tumor suppressor miRNAs (e.g., miR-206, let-7) and overexpression of oncogenic miRNAs (e.g., miR-21, miR-155) observed in breast cancer.
- Key miRNA targets contributing to the disease phenotype have been identified.
- Perturbations in miRNA expression profiles disrupt critical pathways involved in breast cancer progression.
Conclusions:
- Altered miRNA signatures are significantly associated with breast cancer tumorigenesis and metastasis.
- Dysregulation of specific miRNAs contributes to the development and progression of breast cancer.
- Understanding miRNA networks is crucial for deciphering breast cancer pathogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
The Nucleolus

